COMMUNIQUÉS West-GlobeNewswire
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/08/2024 - 14:00 -
Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8
02/08/2024 - 14:00 -
Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System
02/08/2024 - 14:00 -
Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
02/08/2024 - 13:20 -
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/08/2024 - 13:00 -
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results
02/08/2024 - 13:00 -
Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
02/08/2024 - 13:00 -
Algernon Pharmaceuticals Announces Closing of Private Placement
02/08/2024 - 13:00 -
Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
02/08/2024 - 13:00 -
The Ensign Group Grows in Colorado
02/08/2024 - 12:00 -
BrightSpring Health Services, Inc. Reports Second Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
02/08/2024 - 12:00 -
The Ensign Group Acquires Skilled Nursing Facility in Iowa
02/08/2024 - 12:00 -
The Ensign Group Acquires Skilled Nursing Facility in Colorado
02/08/2024 - 12:00 -
EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS
02/08/2024 - 07:30 -
EUROBIO SCIENTIFIC FINALISE L’ACQUISITION DU TEST GÉNOMIQUE ENDOPREDICT® AUPRÈS DE MYRIAD GENETICS
02/08/2024 - 07:30 -
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds
02/08/2024 - 02:31 -
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/08/2024 - 00:50 -
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/08/2024 - 00:00 -
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
01/08/2024 - 22:30
Pages